Spring Selection 2018

read more

currently open
closes 7 Jan 2018

Research Groups

Portrait Stephan Speier

Stephan Speier

Islet Cell Physiology

Previous and Current Research

Diabetes is a growing epidemic with major impact on life style, health and life expectancy of the affected patients. Diabetes develops when systemic insulin concentrations are insufficient to control blood glucose homeostasis. Recent research of our lab and other groups has demonstrated that simultaneous deteriorations of both, number and function of insulin secreting beta cells are the cause of this shortage in insulin. Thereby, the different phases of diabetes pathogenesis are characterized by distinct alterations of beta cell mass and/or function. Based on these findings we believe that parallel targeting of beta cell function and mass is necessary to successfully treat diabetes. Thus, our group aims to discover novel therapeutic targets for type 1, type 2 and gestational diabetes by investigating the role of beta cell mass and function at distinct stages of diabetes pathogenesis and therapy.

Targeting beta cell function

Beta cell function exhibits enormous plasticity in response to various physiological and pathophysiological situations. Under normal conditions functional compensation of insulin secretion significantly contributes to preventing the development of type 2 diabetes and gestational diabetes. However, in diabetes pathogenesis beta cell dysfunction hinders functional compensation resulting in hyperglycemia. Thus, our projects addressing beta cell function aim to reveal the underlying mechanisms of functional compensation and beta cell dysfunction to protect and recover beta cell function in diabetes therapy.

Targeting beta cell mass

Also the number of beta cells can increase during obesity and pregnancy in an attempt to balance the greater insulin demand under these conditions. However, the regenerative mechanisms underlying this enlargement of beta cell mass as well as the reasons for its failure during the development of type 2 diabetes and gestational diabetes are unclear. We aim to understand the bases of beta cell regeneration to enable their induction in the prevention of type 2 diabetes and gestational diabetes. In addition, we use our expertise to facilitate the development of functionally mature beta cells from embryonic stem cells for cell replacement therapies of type 1 diabetes.

Approach

The unique approach of our lab in tackling these tasks is the study of islet of Langerhans mass and function under most physiological conditions. Thereby, we aim to account for the numerous local and systemic signals which regulate the complex physiology of islet pathology and regeneration inside the living organism. For that purpose we have established novel in situ and in vivo technical platforms to complement standard methods of islet research.

A key aspect of our work is the translation of our research to the human situation. Over the last years we have built up national and international collaborations to obtain acute human tissue, giving us the unique opportunity to employ our techniques for the investigation of human diabetes therapies.

Stephan Speier research: figure 1
Figure 1: Longitudinal in vivo observation of autoimmune beta cell destruction during type 1 diabetes progression. Green: beta cells; Magenta: blood vessels; Grey: cell lightscatter. (Chmelova et al, Diabetes, 2015)
Stephan Speier research: figure
Figure 2: Longitudinal in vivo observation of beta cell regeneration in the attempt to prevent type 2 diabetes development during high fat diet feeding (HFD). Green: beta cells; Magenta: blood vessels. (Chen et al, Diabetes, 2016)
Future Projects and Goals
  • Assessing the mechanism of beta cell dysfunction in diabetes pathogenesis
  • Evaluating the mechanism of endogenous islet cell regeneration
  • Facilitating the development of mature stem cell derived beta cells
  • Translation of research findings to human
Methodological and Technical Expertise
  • in vivo, in situ and in vitro two-photon and confocal laser scanning microscopy
  • patch-clamp technique
  • assessment of cell and systemic physiology
  • human and mouse islets of Langerhans and tissue slices
Selected Publications

Chen C, Chmelova H, Cohrs CM, Chouinard JA, Jahn SR, Stertmann J, Uphues I, Speier S
Alterations in β-cell calcium dynamics and efficacy outweigh islet mass adaptation in compensation of insulin resistance and prediabetes onset.
Diabetes; 65:2676–85 (2016)

Chmelova H, Cohrs CM, Chouinard JA, Petzold C, Kuhn M, Chen C, Roeder I, Kretschmer K, Speier S
Distinct roles of beta cell mass and function during type 1 diabetes onset and remission.
Diabetes; 64:2148–2160. (2015)

Marciniak A, Cohrs CM, Tsata V, Chouinard JA, Selck C, Stertmann J, Reichelt S, Rose T, Ehehalt F, Weitz J, Solimena M, Slak Rupnik M, Speier S
Using pancreas tissue slices for in situ studies of islet of Langerhans and acinar cell biology.
Nat Protoc;9:2809–2822 (2014)

Marciniak A, Selck C, Friedrich B, Speier S
Mouse pancreas tissue slice culture facilitates long-term studies of exocrine and endocrine cell physiology in situ.
PLoS One;8:e78706. (2013)

Speier S, Nyqvist D, Cabrera O, Yu J, Molano RD, Pileggi A, Moede T, Kohler M, Wilbertz J, Leibiger B, Ricordi C, Leibiger IB, Caicedo A, Berggren PO
Noninvasive in vivo imaging of pancreatic islet cell biology.
Nat Med;14:574–578 (2008)

CV

since 2016
Professor for Pancreatic Islet Physiology, Faculty of Medicine, TU Dresden

Islet Cell Physiology Group, DZD-Paul Langerhans Institute Dresden of the Helmholtz Zentrum Munich at the University Hospital and Faculty of Medicine, TU Dresden

2009–2016
Group Leader, Center for Regenerative Therapies Dresden (CRTD) and Paul-Langerhans Institute Dresden (PLID)

2010–2015
Emmy Noether Fellow

2005–2009
Postdoctoral Research Fellow, The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institute, Stockholm, Sweden

2004–2005
Postdoctoral Research Fellow, European Neuroscience Institute Göttingen / Max Planck Institute for Biophysical Chemistry, Göttingen, Germany

2001–2004
PhD Thesis, European Neuroscience Institute Göttingen / Max Planck Institute for Biophysical Chemistry, Göttingen, Germany

1994–2000
Diploma degree in Human Biology, Philipps-University Marburg, Institute for Normal and Pathological Physiology, Marburg, Germany

Contact

Paul Langerhans Institute Dresden
Medical Faculty
TU Dresden
Fetscherstraße 74
01307 Dresden

Homepage

Intranet